Quest PharmaTech Inc. (QPTFF)
OTCMKTS · Delayed Price · Currency is USD
0.0133
-0.0017 (-11.33%)
At close: Jul 15, 2024
Quest PharmaTech Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.73M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | - | - | - |
| Jan 31, 2024 | - | - | - |
| Jan 31, 2023 | - | - | - |
| Jan 31, 2022 | - | - | - |
| Jan 31, 2021 | - | - | - |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LakeShore Biopharma | 84.75M |
| Clearside Biomedical | 3.33M |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| AXIM Biotechnologies | 92.90K |
| Enzolytics | 46.59K |
| Enzon Pharmaceuticals | 26.00K |
Quest PharmaTech News
- 6 months ago - Quest PharmaTech Announces Results from AGM - GlobeNewsWire
- 8 months ago - Quest PharmaTech Announces Opposition to OQPBIOM’s Acquisition of AdBioTech - Financial Post
- 8 months ago - Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech - GlobeNewsWire